Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid for Chemotherapy-Induced Neurological Changes in Breast Cancer
NCT06406127Phase 4Recruiting
- Sponsor
- Ain Shams University
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alpha-lipoic acid in chemotherapy-induced cognitive impairment (CICI), sponsored by Ain Shams University. Started Apr 2024; status: recruiting.
02
Drugs
alpha-lipoic acid
03
Conditions
chemotherapy-induced cognitive impairment (CICI)
Beyond the preview
Go deeper on NCT06406127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06406127.